MedVellum
MedVellum
Back to Library

SVT (Supraventricular Tachycardia)

On This Page

Overview

SVT (Supraventricular Tachycardia)

Quick Reference

Critical Alerts

  • Unstable = Cardiovert: Hypotension, AMS, chest pain, acute heart failure
  • Adenosine is diagnostic AND therapeutic: Terminates most re-entrant SVTs
  • Give adenosine rapidly: Push fast with flush, closest port possible
  • Wide complex SVT may be VT: If unsure, treat as VT
  • Vagal maneuvers first: Safe, can terminate
  • WPW with AF is DANGEROUS: Avoid AV nodal blockers

Key Diagnostics

TestFindingSignificance
Rate150-250 bpmTypical for SVT
QRSNarrow (<120 ms)Supraventricular origin
RhythmRegular (usually)Irregular = AF, MAT
P wavesOften absent or retrogradeHidden in QRS or ST
Response to adenosineTerminates or unmasksDiagnostic

Emergency Treatments

ConditionTreatmentDose
Stable SVT - First lineVagal maneuversModified Valsalva
Stable SVT - If vagal failsAdenosine6 mg rapid IV push → 12 mg → 12 mg
Unstable SVTSynchronized cardioversion50-100 J (biphasic)
Rate control (if SVT persists)Diltiazem or MetoprololDiltiazem 15-20 mg IV (or 0.25 mg/kg)
WPW with AF (wide irregular)Procainamide or CardioversionDO NOT give AV nodal blockers

Definition

Overview

Supraventricular tachycardia (SVT) is a broad term encompassing any tachyarrhythmia arising from above the ventricles. In clinical practice, "SVT" often specifically refers to paroxysmal supraventricular tachycardia (PSVT), a narrow complex, regular tachycardia typically due to re-entrant mechanisms. Most are benign but can cause significant symptoms and rarely hemodynamic compromise.

Classification

Types of SVT:

TypeMechanismFrequency
AVNRTRe-entry within AV node60-70%
AVRT (accessory pathway)Re-entry using bypass tract20-30%
Atrial tachycardiaEnhanced automaticity or micro-reentry in atrium5-10%

Other Supraventricular Tachycardias (Broader Definition):

ArrhythmiaFeatures
Atrial fibrillationIrregularly irregular
Atrial flutterRegular, flutter waves
Multifocal atrial tachycardiaIrregular, ≥3 P wave morphologies
Sinus tachycardiaAppropriate for clinical context

AVNRT (AV Nodal Reentrant Tachycardia)

  • Most common PSVT
  • Two pathways within AV node (slow and fast)
  • Typical AVNRT: Antegrade slow, retrograde fast
  • P waves buried in or just after QRS
  • "Pseudo R′" in V1 or "pseudo S" in inferior leads

AVRT (AV Reentrant Tachycardia)

  • Uses accessory pathway (bypass tract)
  • Orthodromic (most common): Antegrade AV node, retrograde accessory pathway → Narrow QRS
  • Antidromic (rare): Antegrade accessory pathway, retrograde AV node → Wide QRS
  • WPW syndrome: Pre-excitation (delta wave) at baseline

Epidemiology

  • Prevalence of PSVT: 2.3 per 1000 adults
  • Incidence: 35 episodes per 100,000 person-years
  • Age: AVNRT more common in adults; AVRT more common in younger patients
  • Gender: AVNRT more common in women (2:1)
  • WPW prevalence: 1-3 per 1000

Etiology

Precipitants:

FactorMechanism
Caffeine, alcoholSympathetic stimulation
Stress, anxietyCatecholamines
MedicationsDecongestants, stimulants
Sleep deprivationAutonomic tone
Electrolyte abnormalitiesCardiac irritability
HyperthyroidismIncreased adrenergic activity
Structural heart disease(Less common in SVT)

Pathophysiology

Re-Entry Mechanism

Requirements for Re-Entry:

  1. Two pathways with different conduction velocities and refractory periods
  2. Unidirectional block in one pathway
  3. Slow conduction in the other pathway
  4. Completed circuit allowing continuous loop

AVNRT:

  • Slow and fast pathways within AV node
  • PAC blocks in fast pathway → conducts down slow pathway → retrograde up fast pathway
  • Continuous circuit

AVRT:

  • Circuit includes atria, AV node, ventricles, and accessory pathway
  • Orthodromic: Down AV node, up accessory pathway
  • Antidromic: Down accessory pathway, up AV node

Hemodynamic Effects

  • Loss of AV synchrony (atrial contraction after ventricular)
  • Reduced diastolic filling time (fast rate)
  • Usually tolerated in structurally normal hearts
  • May cause hypotension in patients with heart disease

WPW Danger with Atrial Fibrillation

  • Rapid conduction directly to ventricles via accessory pathway
  • Can conduct 1:1 at very fast rates (>250 bpm)
  • AV nodal blockers paradoxically increase conduction through accessory pathway
  • Can degenerate to VF

Clinical Presentation

Symptoms

Typical:

Polyuria: Common during/after episode (atrial natriuretic peptide release)

"Flip" sensation: Moment of initiation or termination

Syncope: Rare; more common with very fast rates or underlying heart disease

History

Key Questions:

Physical Examination

Vital Signs:

FindingTypical Value
Heart rate150-250 bpm
Blood pressureUsually maintained; may be low
Respiratory rateOften elevated
SpO2Usually normal

Cardiovascular:

Signs of Instability:


Sudden onset palpitations
Common presentation.
Awareness of rapid/strong heartbeat
Common presentation.
Lightheadedness
Common presentation.
Chest discomfort
Common presentation.
Dyspnea
Common presentation.
Anxiety
Common presentation.
Red Flags

Unstable SVT (Cardiovert Immediately)

FindingConcernAction
Hypotension (SBP <90)Hemodynamic compromiseSynchronized cardioversion
Altered mental statusHypoperfusionSynchronized cardioversion
Severe chest painIschemiaSynchronized cardioversion
Acute pulmonary edemaHeart failureSynchronized cardioversion
Signs of shockEnd-organ dysfunctionSynchronized cardioversion

Wide Complex SVT

ConcernAction
May be VTIf unsure, treat as VT
WPW with antidromic conductionAdenosine may be used cautiously
SVT with aberrancyAdenosine diagnostic
WPW with AF (irregularly irregular wide)AVOID AV nodal blockers

Differential Diagnosis

Narrow Complex Tachycardia

DiagnosisFeatures
SVT (PSVT)Regular, rate 150-250, sudden onset/offset
Sinus tachycardiaGradual onset, P waves before QRS, appropriate for clinical state
Atrial flutterRegular (often ~150 bpm with 2:1 block), sawtooth flutter waves
Atrial fibrillationIrregularly irregular
MATIrregular, ≥3 different P wave morphologies

Wide Complex Tachycardia

DiagnosisFeatures
VTWide, often regular, AV dissociation
SVT with aberrancy (LBBB, RBBB)Bundle branch block at fast rate
SVT with preexisting BBBKnown prior BBB
Antidromic AVRTWPW with antegrade accessory pathway
WPW with AFIrregularly irregular, wide, variable morphology

When in Doubt: Treat wide complex tachycardia as VT


Diagnostic Approach

ECG Interpretation

Systematic Approach:

  1. Rate (usually 150-250 bpm)
  2. Regularity (regular in PSVT; irregular = AF, flutter with variable block, MAT)
  3. QRS width (narrow <120 ms = supraventricular)
  4. P waves (look for hidden P waves in ST or T waves)
  5. Compare to prior ECG (baseline BBB? Pre-excitation?)

Finding Hidden P Waves:

LocationSuggests
In QRS (pseudo R′ in V1)AVNRT
Just after QRS (short RP)AVNRT or AVRT
Between QRS complexes (long RP)Atrial tachycardia
Sawtooth in inferior leadsAtrial flutter

Laboratory Studies

TestPurpose
Electrolytes (K, Mg)Arrhythmia triggers
TSHHyperthyroidism
TroponinIf chest pain or prolonged episode
BNPIf heart failure concern
Drug screenIf concern for stimulants

Response to Adenosine

ResponseInterpretation
TerminatesAVNRT or AVRT (most likely)
Transiently slows then resumesAtrial tachycardia, atrial flutter (reveals underlying rhythm)
No effectLikely VT if wide; may need higher dose

Treatment

Principles of Management

  1. Assess stability: Unstable → Cardiovert
  2. Stable SVT: Vagal maneuvers → Adenosine → Other agents
  3. Identify the rhythm: ECG during episode
  4. Treat underlying causes: Electrolytes, hyperthyroidism
  5. Prevent recurrence: Ablation, long-term medications

Unstable SVT: Synchronized Cardioversion

Indications:

  • Hypotension, altered mental status, severe chest pain, acute heart failure

Technique:

StepDetails
SedationBrief (etomidate, propofol, midazolam) if time allows
Sync modeEnsure "sync" is activated
Energy50-100 J biphasic (start low for SVT)
ShockDeliver on R wave
Re-assessRepeat if needed, increase energy

Stable SVT: Vagal Maneuvers

Modified Valsalva (REVERT Trial):

  1. Patient semi-recumbent at 45°
  2. Blow into 10 mL syringe for 15 seconds (create resistance)
  3. Immediately lie flat and raise legs to 45° for 15 seconds
  4. Return to sitting

Success Rate: Up to 40-50% with modified technique

Other Vagal Maneuvers:

  • Carotid sinus massage (if no carotid bruit, elderly caution)
  • Cold water to face (diving reflex)
  • Bearing down

Stable SVT: Adenosine

DoseAdministration
6 mgRapid IV push closest to heart (antecubital), immediate 20 mL NS flush
12 mgIf no response after 1-2 minute, repeat
12 mgMay repeat once more

Special Considerations:

SituationAdjustment
Central lineStart with 3 mg
Theophylline/CaffeineMay need higher dose
Dipyridamole or CarbamazepineUse lower dose
Transplant heartStart with 1 mg

Warn Patient: Brief chest discomfort, dyspnea, flushing (lasts seconds)

Contraindications:

  • Asthma (relative)
  • Second or third degree heart block (without pacemaker)
  • Sick sinus syndrome (without pacemaker)

Stable SVT: If Adenosine Fails

Calcium Channel Blockers:

DrugDose
Diltiazem0.25 mg/kg IV (typically 15-20 mg) over 2 min; may repeat 0.35 mg/kg
Verapamil2.5-5 mg IV over 2 min; may repeat up to 20 mg total

Beta-Blockers:

DrugDose
Metoprolol5 mg IV q5min up to 15 mg
Esmolol500 mcg/kg bolus, then 50-200 mcg/kg/min infusion

Avoid in:

  • Hypotension
  • Severe heart failure
  • WPW with AF

WPW with Atrial Fibrillation

DO NOT GIVE:

  • Adenosine
  • Beta-blockers
  • Calcium channel blockers
  • Digoxin
  • Amiodarone (controversial; some avoid)

Treatment Options:

OptionDetails
Synchronized cardioversionIf unstable
Procainamide20-50 mg/min IV (up to 17 mg/kg), then 1-4 mg/min
Ibutilide1 mg IV over 10 min (can repeat)

Rate Control (If SVT Persists)

Diltiazem Infusion: 5-15 mg/hr after bolus

Preventing Recurrence

Lifestyle:

  • Avoid triggers (caffeine, alcohol, decongestants)
  • Adequate sleep

Long-Term Medications:

Drug ClassExample
Beta-blockerMetoprolol
Calcium channel blockerDiltiazem, Verapamil
Antiarrhythmics (rarely)Flecainide, Propafenone (pill-in-pocket)

Catheter Ablation:

  • Definitive treatment for recurrent SVT
  • High success rate (95%+ for AVNRT, 90%+ for AVRT)
  • Low complication rate
  • Recommended for frequent/symptomatic episodes

Disposition

Discharge Criteria

  • Converted to sinus rhythm
  • Hemodynamically stable
  • First episode with clear precipitant
  • No concerning symptoms at presentation
  • Able to follow up

Admission Criteria

  • Prolonged episode requiring multiple interventions
  • Underlying cardiac disease
  • Cardiac ischemia
  • Heart failure
  • Unable to convert or maintain sinus rhythm
  • Requires initiation of antiarrhythmic

Cardiology Follow-Up

  • All new SVT episodes
  • Consider Holter/event monitor if diagnosis uncertain
  • Ablation referral for recurrent episodes

Patient Education

Condition Explanation

  • "Your heart went into a fast rhythm called SVT."
  • "It's caused by an electrical 'short circuit' in the heart."
  • "It's usually not dangerous, but it makes you feel awful."
  • "We were able to fix it with [describe treatment]."

Vagal Maneuvers at Home

  • Teach modified Valsalva
  • "Try these at home if it happens again."
  • "If you feel faint, have chest pain, or can't stop it, call 911."

Warning Signs

  • Prolonged episode (>15-20 minutes)
  • Chest pain
  • Syncope or near-syncope
  • Severe shortness of breath

Lifestyle Modifications

  • Reduce caffeine
  • Limit alcohol
  • Manage stress
  • Adequate sleep
  • Avoid decongestants

Special Populations

WPW Syndrome

  • Pre-excitation on baseline ECG (short PR, delta wave)
  • Risk of sudden death if AF develops (rapid ventricular rate)
  • Ablation recommended for symptomatic WPW
  • Avoid AV nodal blockers if AF develops

Pregnancy

  • SVT relatively common
  • Vagal maneuvers first
  • Adenosine is safe
  • Beta-blockers relatively safe (prefer metoprolol, labetalol)
  • Avoid electrical cardioversion unless unstable (safe if needed)

Pediatric

  • AVRT more common than AVNRT in children
  • WPW more commonly symptomatic
  • Adenosine dosing: 0.1 mg/kg (max 6 mg), then 0.2 mg/kg (max 12 mg)
  • Vagal maneuvers: Ice to face (diving reflex)

Elderly

  • More likely to have underlying heart disease
  • More sensitive to hypotension
  • Use lower doses of medications
  • Carotid massage with caution (check for bruits)

Quality Metrics

Performance Indicators

MetricTargetRationale
ECG obtained during tachycardia100%Diagnostic
Vagal maneuvers attempted>0%Non-invasive, effective
Adenosine given if vagal fails>0%First-line pharmacotherapy
Cardioversion for unstable100%Life-saving
Cardiology follow-up arranged100%Ongoing management

Documentation Requirements

  • ECG during tachyarrhythmia
  • Rate, rhythm, QRS width
  • Stability assessment
  • Interventions and response
  • Rhythm at discharge
  • Follow-up plan

Key Clinical Pearls

Diagnostic Pearls

  • Regular narrow complex at 150 bpm: May be flutter with 2:1 block—look for flutter waves
  • Pseudo R′ in V1: Think AVNRT
  • Compare to prior ECG: Baseline BBB or pre-excitation?
  • Adenosine is diagnostic: Watch the response on the monitor
  • Wide complex + irregular: WPW with AF until proven otherwise
  • Short RP interval: Likely AVNRT or orthodromic AVRT

Treatment Pearls

  • Modified Valsalva works better: Leg elevation component is key
  • Push adenosine FAST: With immediate saline flush
  • Warn the patient: "You'll feel strange for a few seconds"
  • Have defibrillator ready: Rarely degenerates
  • If adenosine fails twice, move on: Rate control or cardioversion
  • NEVER AV nodal blockers in WPW + AF: Can cause VF

Disposition Pearls

  • Most SVT can go home: If converted, stable, first or rare episode
  • Teach vagal maneuvers: Patient empowerment
  • Refer all for cardiology follow-up: Consider ablation
  • WPW needs urgent outpatient EP referral: Definitive treatment is ablation

References
  1. Page RL, et al. 2015 ACC/AHA/HRS Guideline for the Management of Adult Patients With Supraventricular Tachycardia. Circulation. 2016;133(14):e506-e574.
  2. Appelboam A, et al. Postural modification to the standard Valsalva manoeuvre for emergency treatment of supraventricular tachycardias (REVERT): a randomised controlled trial. Lancet. 2015;386(10005):1747-1753.
  3. Brugada J, et al. 2019 ESC Guidelines for the management of patients with supraventricular tachycardia. Eur Heart J. 2020;41(5):655-720.
  4. Chhabra L, et al. Wolff-Parkinson-White syndrome. Am Fam Physician. 2010;82(8):963-968.
  5. Link MS. Evaluation and Initial Treatment of Supraventricular Tachycardia. N Engl J Med. 2012;367(15):1438-1448.
  6. January CT, et al. 2014 AHA/ACC/HRS Guideline for the Management of Patients With Atrial Fibrillation. Circulation. 2014;130(23):e199-e267.
  7. UpToDate. Narrow QRS complex tachycardias: Clinical manifestations, diagnosis, and evaluation. 2024.
  8. UpToDate. Overview of the acute management of tachyarrhythmias. 2024.

At a Glance

EvidenceStandard
Last UpdatedRecently

Guidelines

  • NICE Guidelines
  • BTS Guidelines
  • RCUK Guidelines